KALA BIO, Inc.
US ˙ NasdaqCM ˙ US4831192020

Introduction

This page provides a comprehensive analysis of the known insider trading history of Myers C. Daniel. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Myers C. Daniel has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:KALA / KALA BIO, Inc. Director 10,374
US:ALIM / Alimera Sciences, Inc. Director 6,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Myers C. Daniel. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases KALA / KALA BIO, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in KALA / KALA BIO, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

KALA / KALA BIO, Inc. Insider Trades
Insider Sales KALA / KALA BIO, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in KALA / KALA BIO, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

KALA / KALA BIO, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Myers C. Daniel as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-06-17 2025-06-15 4 KALA KALA BIO, Inc.
Common Stock
A - Award 2,450 10,374 30.92
2024-06-12 2024-06-11 4 KALA KALA BIO, Inc.
Common Stock
A - Award 1,400 7,924 21.46
2023-06-23 2023-06-22 4 KALA Kala Pharmaceuticals, Inc.
Common Stock
A - Award 1,100 6,524 20.28
2023-06-23 2023-06-22 4 KALA Kala Pharmaceuticals, Inc.
Common Stock
A - Award 3,784 5,424 230.73
2023-06-02 2023-05-31 4 KALA Kala Pharmaceuticals, Inc.
Common Stock
A - Award 1,640 1,640
2021-11-04 2021-11-02 4 ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 6,000 6,000
2021-10-19 2021-10-15 4 KALA Kala Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 42,000 42,000
2020-08-24 2020-08-20 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale -5,000 5,578 -47.27 6.73 -33,650 37,540
2020-06-22 2020-06-18 4 ALIM ALIMERA SCIENCES INC
Stock Option (Right to Buy)
A - Award 3,333 3,333
2019-06-20 2019-06-19 4 ALIM ALIMERA SCIENCES INC
Stock Option (Right to Buy)
A - Award 50,000 50,000
2019-02-06 2019-02-05 4 ALIM ALIMERA SCIENCES INC
Common Stock
F - Taxes X -21,966 158,676 -12.16 0.98 -21,472 155,106
2019-02-06 2019-02-04 4 ALIM ALIMERA SCIENCES INC
Common Stock
F - Taxes X -21,966 180,642 -10.84 0.94 -20,648 169,803
2018-02-08 2017-10-31 5 ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 2,494 202,608 1.25 1.05 2,607 211,827
2018-02-08 2017-04-28 5 ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 2,453 200,114 1.24 1.06 2,606 212,621
2018-02-08 2017-02-15 5 ALIM ALIMERA SCIENCES INC
Common Stock
G - Gift -500 197,661 -0.25
2018-02-08 2017-02-15 5 ALIM ALIMERA SCIENCES INC
Common Stock
G - Gift -500 198,161 -0.25
2018-02-08 2017-02-15 5 ALIM ALIMERA SCIENCES INC
Common Stock
G - Gift -500 198,661 -0.25
2018-01-25 2018-01-22 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 395,000 395,000 1.16 458,200 458,200
2018-01-25 2018-01-22 4 ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 124,100 199,161 165.33
2018-01-19 2018-01-19 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -26,450 75,061 -26.06 1.18 -31,216 88,587
2018-01-19 2018-01-18 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -26,450 101,511 -20.67 1.22 -32,163 123,437
2018-01-18 2018-01-17 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -26,450 127,961 -17.13 1.23 -32,560 157,520
2018-01-18 2018-01-16 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -26,450 154,411 -14.62 1.24 -32,735 191,099
2017-03-13 2017-03-10 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale -21,172 180,861 -10.48 1.39 -29,429 251,397
2017-02-13 2016-10-31 5 ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 2,455 98,791 2.55 1.06 2,608 104,965
2017-02-13 2016-04-29 5 ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 2,103 96,336 2.23 1.89 3,968 181,786
2017-02-13 2016-03-18 5 ALIM ALIMERA SCIENCES INC
Common Stock
G - Gift -1,000 94,233 -1.05
2017-02-13 2016-02-09 5 ALIM ALIMERA SCIENCES INC
Common Stock
G - Gift -1,000 95,233 -1.04
2017-02-13 2016-01-12 5 ALIM ALIMERA SCIENCES INC
Common Stock
G - Gift -1,000 96,233 -1.03
2017-01-23 2017-01-20 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 425,000 425,000
2017-01-23 2017-01-20 4 ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 105,800 202,033 109.94
2016-10-13 2016-10-11 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
M - Exercise -55,147 0 -100.00 1.33 -73,346
2016-10-13 2016-10-11 4 ALIM ALIMERA SCIENCES INC
Common Stock
F - Taxes -48,898 96,233 -33.69 1.50 -73,347 144,350
2016-10-13 2016-10-11 4 ALIM ALIMERA SCIENCES INC
Common Stock
M - Exercise 55,147 145,131 61.29 1.33 73,346 193,024
2016-01-06 2016-01-04 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 450,000 450,000
2015-11-16 2015-10-30 4 ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 989 89,984 1.11 2.56 2,530 230,224
2015-11-16 2015-05-01 4/A ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -2,000 88,995 -2.20 4.37 -8,740 388,908
2015-11-16 2015-04-30 4/A ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 678 90,995 0.75 3.71 2,513 337,227
2015-05-04 2015-05-01 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -2,000 88,980 -2.20 4.37 -8,740 388,843
2015-05-04 2015-04-30 4 ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 663 90,980 0.73 3.79 2,513 344,905
2015-04-03 2015-04-01 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -2,000 90,317 -2.17 4.92 -9,840 444,360
2015-03-03 2015-03-02 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -2,000 92,317 -2.12 5.21 -10,420 480,972
2015-03-03 2015-02-19 4 ALIM ALIMERA SCIENCES INC
Common Stock
G - Gift -2,000 94,317 -2.08
2015-02-04 2015-02-02 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -2,000 96,317 -2.03 5.43 -10,860 523,001
2015-02-04 2015-01-07 4 ALIM ALIMERA SCIENCES INC
Common Stock
G - Gift -4,500 98,317 -4.38
2015-02-02 2015-01-29 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 450,000 450,000
2015-01-06 2015-01-02 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -2,000 102,817 -1.91 5.51 -11,020 566,522
2014-12-02 2014-12-01 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -2,000 104,817 -1.87 5.99 -11,980 627,854
2014-11-05 2014-11-03 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -2,000 106,817 -1.84 5.35 -10,700 571,471
2014-11-05 2014-10-31 4 ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 460 108,817 0.42 4.84 2,229 527,218
2014-10-02 2014-10-01 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -2,000 108,357 -1.81 5.42 -10,840 587,295
2014-09-04 2014-09-02 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -2,000 110,357 -1.78 6.19 -12,380 683,110
2014-06-10 2014-06-06 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale -5,000 111,130 -4.31 5.56 -27,800 617,883
2014-03-05 2014-03-04 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
M - Exercise -22,775 0 -100.00
2014-03-05 2014-03-04 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale -22,775 116,130 -16.40 7.10 -161,702 824,523
2014-03-05 2014-03-04 4 ALIM ALIMERA SCIENCES INC
Common Stock
M - Exercise 22,775 138,905 19.61 2.04 46,461 283,366
2014-02-10 2013-12-18 5 ALIM ALIMERA SCIENCES INC
Common Stock
G - Gift -4,000 116,130 -3.33
2013-12-18 2013-12-16 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 110,000 110,000
2013-12-18 2013-12-16 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 365,000 365,000
2012-12-21 2012-12-19 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 110,000 110,000
2012-12-21 2012-12-19 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 365,000 365,000
2012-12-05 2012-12-03 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -7,700 117,900 -6.13 1.95 -14,997 229,634
2012-11-21 2011-12-22 5/A ALIM ALIMERA SCIENCES INC
Common Stock
G - Gift -4,500 140,264 -3.11
2012-11-05 2012-11-01 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -5,950 124,616 -4.56 2.52 -14,979 313,708
2012-11-05 2012-10-26 4 ALIM ALIMERA SCIENCES INC
Common Stock
G - Gift -4,000 130,566 -2.97
2012-10-03 2012-10-01 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -5,900 139,066 -4.07 2.52 -14,851 350,043
2012-09-05 2012-09-04 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -6,350 144,966 -4.20 2.36 -14,986 342,120
2012-08-14 2012-08-13 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -6,745 151,316 -4.27 2.22 -14,985 336,164
2012-08-14 2012-08-13 4 ALIM ALIMERA SCIENCES INC
Common Stock
F - Taxes -6,388 158,061 -3.88 2.28 -14,565 360,379
2012-07-20 2012-07-18 4 ALIM ALIMERA SCIENCES INC
Common Stock
A - Award 19,685 164,449 13.60
2012-02-14 2012-02-10 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 95,000 95,000
2012-02-14 2012-02-10 4 ALIM ALIMERA SCIENCES INC
Employee Stock Option (Right to Buy)
A - Award 300,000 300,000
2012-02-14 2011-03-03 5 ALIM ALIMERA SCIENCES INC
Common Stock
G - Gift -3,500 144,764 -2.36
2012-02-14 2011-03-02 5 ALIM ALIMERA SCIENCES INC
Common Stock
G - Gift -1,000 148,264 -0.67
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)